1293. In vitro Activity of Ceftibuten in Combination with VNRX-5236 against Clinical Isolates of Enterobacterales from Urinary Tract Infections Collected in 2018-2020

BACKGROUND: Increasing resistance among agents commonly prescribed to treat urinary tract infections indicate that new oral agents are urgently needed. Ceftibuten in combination with VNRX-7145 is under development as an oral treatment for complicated urinary tract infections caused by serine β-lacta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackel, Meredith, Wise, Mark G G, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643729/
http://dx.doi.org/10.1093/ofid/ofab466.1485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643729/
http://dx.doi.org/10.1093/ofid/ofab466.1485

Ejemplares similares